Description of Invention:
Myasthenia gravis is a disease that causes muscle weakness and paralysis due to an autoimmune process that attacks the muscle. So far no mouse model has been available which has limited investigation of the disease and the development of better treatments or a cure. Our inventors have created a transgenic mouse strain that manifests immunological reactivity that underlines myasthenia gravis.
Inventors:
Dr. Michael J. Lenardo et al. (NIAID)
Patent Status:
DHHS Reference No. E-188-1999/0 -- Research Tool
Portfolios: Devices/Instrumentation
Devices/Instrumentation-Research Materials-Biologicals and Chemicals Devices/Instrumentation-Research Materials
For Additional Information Please Contact: Jasbir (Jesse) S. Kindra J.D.
NIH Office of Technology Transfer
6011 Executive Blvd, Suite 325
Rockville, MD 20852-3804
Phone: (301) 435-5559
Email: kindraj@mail.nih.gov
Fax: (301) 402-0220
